SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report)’s share price traded down 1.2% on Monday . The stock traded as low as $24.38 and last traded at $24.38. 200 shares changed hands during mid-day trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Trading Down 1.2 %
The company has a market cap of $6.64 billion, a PE ratio of 48.76, a P/E/G ratio of 1.30 and a beta of 1.81. The firm has a 50 day moving average of $24.38 and a two-hundred day moving average of $24.38.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
Further Reading
- Five stocks we like better than SWEDISH ORPHAN/S
- Investing in Construction Stocks
- High-Yield Texas Instruments Could Hit New Highs Soon
- Conference Calls and Individual Investors
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- 3 REITs to Buy and Hold for the Long Term
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
